426 results on '"Hissaria, Pravin"'
Search Results
2. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
3. The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) – Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions
4. PEGylated liposomes for diagnosis of polyethylene glycol allergy
5. Hereditary angioedema prevalence and satisfaction with prophylaxis in South Australia
6. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
7. Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
8. Antibiotic prophylaxis in immunosuppressed patients – Missed opportunities from trimethoprim-sulfamethoxazole allergy label
9. The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study
10. Evaluation of glutamic acid decarboxylase (GAD) 65 antibody detection methods for neurological and diabetic investigation in an Australian diagnostic laboratory
11. Lenalidomide Desensitization for Delayed Cutaneous Reaction: A Case Series and Review of the Literature
12. AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy
13. Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients
14. Myopericarditis following both BNT162b2 and NVX-CoV2373
15. Lack of standardisation in interpretation and reporting of autoantibody assays: a survey analysis of Australasian laboratories with focus on line immunoassays
16. Outcomes of serum food-specific IgG4 to guide elimination diet in patients with eosinophilic esophagitis
17. 314.2: MTOR Inhibitors Promote Highly Functional T Cell Immunity in Kidney Transplant Recipients Vaccinated Against COVID-19
18. Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency
19. Recurrent orbital inflammation associated with VEXAS syndrome.
20. Outcomes of Serum Food-Specific Immunoglobulin G4 to Guide Elimination Diet in Patients With Eosinophilic Esophagitis.
21. Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial.
22. Validation of phospholipase A2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis
23. A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group
24. Immune profiling of COVID-19 vaccine responses in people with multiple sclerosis on B cell-depleting therapy
25. The role of major and minor determinants in penicillin allergy testing: Time to revisit an old friend?
26. B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotictreated mice.
27. Autoantibodies to mRNA processing pathways (glycine and tryptophan-rich bodies antibodies): prevalence and clinical utility in a South Australian cohort
28. Prevention of exercise-induced anaphylaxis by ibrutinib
29. Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy
30. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZY‐IL1 in Three Patients with Cryopyrin‐Associated Periodic Syndromes.
31. Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study
32. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZY‐IL1 in Three Patients with Cryopyrin‐Associated Periodic Syndromes
33. B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotic-treated mice
34. Adverse Reactions Associated with Intravenous Immunoglobulin Administration in the Treatment of Neurological Disorders: A Systematic Review
35. Tofacitinib as a biologic response modifier in VEXAS syndrome: A case series.
36. Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations
37. Human leukocyte antigen association with azathioprine-induced drug hypersensitivity reactions in patients with anti-neutrophil cytoplasmic antibody associated vasculitis
38. Basophil reactivity to BNT162b2 in COVID‐19 convalescence
39. Australian recommendations on tapering of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs in inflammatory arthritis
40. The role of major and minor determinants in penicillin allergy testing: Time to re-visit an old friend?
41. B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotic-treated mice
42. Recurrent orbital inflammation associated with VEXAS syndrome
43. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia
44. VEXAS syndrome causing fever of unknown origin
45. Parasitic infection and immunomodulation: A possible explanation for the hygiene hypothesis in autoimmune and allergic disease
46. EVOLVE: The Australian Rheumatology Association’s ‘top five’ list of investigations and interventions doctors and patients should question
47. Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19
48. Additional file 10 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
49. Additional file 3 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
50. Additional file 2 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.